TP53 and acute lymphoblastic leukemia: Here, we present a 25-year old XLA patient who developed pre-B acute lymphocytic leukemia (ALL) with somatic <i>TP53</i> mutation, and treatment for this high-risk malignancy involved full myeloablative conditioning and a HLA-matched sibling alloSCT.